117 related articles for article (PubMed ID: 31103522)
1. Early initiation of a factor Xa inhibitor can attenuate tissue repair and neurorestoration after middle cerebral artery occlusion.
Komori M; Ago T; Wakisaka Y; Nakamura K; Tachibana M; Yoshikawa Y; Shibahara T; Yamanaka K; Kuroda J; Kitazono T
Brain Res; 2019 Sep; 1718():201-211. PubMed ID: 31103522
[TBL] [Abstract][Full Text] [Related]
2. Pericyte-Mediated Tissue Repair through PDGFRβ Promotes Peri-Infarct Astrogliosis, Oligodendrogenesis, and Functional Recovery after Acute Ischemic Stroke.
Shibahara T; Ago T; Nakamura K; Tachibana M; Yoshikawa Y; Komori M; Yamanaka K; Wakisaka Y; Kitazono T
eNeuro; 2020; 7(2):. PubMed ID: 32046974
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine-1-Phosphate Receptor 1 Activation Enhances Leptomeningeal Collateral Development and Improves Outcome after Stroke in Mice.
Iwasawa E; Ishibashi S; Suzuki M; Li F; Ichijo M; Miki K; Yokota T
J Stroke Cerebrovasc Dis; 2018 May; 27(5):1237-1251. PubMed ID: 29337049
[TBL] [Abstract][Full Text] [Related]
4. Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study.
Yasaka M; Minematsu K; Toyoda K; Yamagami H; Yoshimura S; Nagao T; Mori E; Hirano T; Hamasaki T; Yamaguchi T
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1342-8. PubMed ID: 26987488
[TBL] [Abstract][Full Text] [Related]
5. Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T.
Barber PA; Hoyte L; Kirk D; Foniok T; Buchan A; Tuor U
Neurosci Lett; 2005 Nov; 388(1):54-9. PubMed ID: 16055267
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment with rivaroxaban attenuates stroke severity in rats by a dual antithrombotic and anti-inflammatory mechanism.
Dittmeier M; Kraft P; Schuhmann MK; Fluri F; Kleinschnitz C
Thromb Haemost; 2016 Apr; 115(4):835-43. PubMed ID: 26489881
[TBL] [Abstract][Full Text] [Related]
7. Reduction of intracerebral hemorrhage by rivaroxaban after tPA thrombolysis is associated with downregulation of PAR-1 and PAR-2.
Morihara R; Yamashita T; Kono S; Shang J; Nakano Y; Sato K; Hishikawa N; Ohta Y; Heitmeier S; Perzborn E; Abe K
J Neurosci Res; 2017 Sep; 95(9):1818-1828. PubMed ID: 28035779
[TBL] [Abstract][Full Text] [Related]
8. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of Oral Xa Inhibitor for Management of Ischemic Stroke Associated with Thrombosis in the Pulmonary Vein Stump after Lung Resection.
Amemiya T; Shono T; Yamagami K; Takagishi S; Toma H; Kobarai T; Eguchi T; Hirota I
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104321. PubMed ID: 31422005
[TBL] [Abstract][Full Text] [Related]
10. Fumarate decreases edema volume and improves functional outcome after experimental stroke.
Clausen BH; Lundberg L; Yli-Karjanmaa M; Martin NA; Svensson M; Alfsen MZ; Flæng SB; Lyngsø K; Boza-Serrano A; Nielsen HH; Hansen PB; Finsen B; Deierborg T; Illes Z; Lambertsen KL
Exp Neurol; 2017 Sep; 295():144-154. PubMed ID: 28602832
[TBL] [Abstract][Full Text] [Related]
11. Anti-Xa Activity and Event Risk in Patients With Direct Factor Xa Inhibitors Initiated Early After Stroke.
Wada S; Toyoda K; Sato S; Matsuki T; Okata T; Kumamoto M; Tagawa N; Inoue M; Okamoto A; Ihara M; Kitazono T; Miyata T; Koga M
Circ J; 2018 Oct; 82(11):2872-2879. PubMed ID: 30210082
[TBL] [Abstract][Full Text] [Related]
12. Thrombolysis with rt-PA under Rivaroxaban Anticoagulation in a Hypertensive Rat Model of Intraluminal Middle Cerebral Artery Occlusion.
Izuma H; Oka F; Ishihara H; Inoue T; Suehiro E; Nomura S; Suzuki M
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2761-2767. PubMed ID: 30056000
[TBL] [Abstract][Full Text] [Related]
13. Intravenous thrombolysis for acute ischemic stroke in a patient receiving rivaroxaban.
Landais A; Ginoux C
J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):e73-4. PubMed ID: 25561312
[TBL] [Abstract][Full Text] [Related]
14. The factor Xa inhibitor rivaroxaban reduces cardiac dysfunction in a mouse model of myocardial infarction.
Bode MF; Auriemma AC; Grover SP; Hisada Y; Rennie A; Bode WD; Vora R; Subramaniam S; Cooley B; Andrade-Gordon P; Antoniak S; Mackman N
Thromb Res; 2018 Jul; 167():128-134. PubMed ID: 29843086
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow mononuclear cells exert long-term neuroprotection in a rat model of ischemic stroke by promoting arteriogenesis and angiogenesis.
Wang J; Yu L; Jiang C; Chen M; Ou C; Wang J
Brain Behav Immun; 2013 Nov; 34():56-66. PubMed ID: 23891963
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting 12/15-lipoxygenase to treat acute stroke in permanent and tPA induced thrombolysis models.
Karatas H; Eun Jung J; Lo EH; van Leyen K
Brain Res; 2018 Jan; 1678():123-128. PubMed ID: 29079502
[TBL] [Abstract][Full Text] [Related]
17. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
Murakami K; Suzuki M; Suzuki N; Hamajo K; Tsukamoto T; Shimojo M
Brain Res; 2013 Aug; 1526():84-93. PubMed ID: 23791950
[TBL] [Abstract][Full Text] [Related]
18. The function of the adrenocortical axis in permanent middle cerebral artery occlusion: effect of glucocorticoids on the neurological outcome.
Weidenfeld J; Leker RR; Gai N; Teichner A; Bener D; Ovadia H
Brain Res; 2011 Aug; 1407():90-6. PubMed ID: 21741032
[TBL] [Abstract][Full Text] [Related]
19. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
[TBL] [Abstract][Full Text] [Related]
20. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with rivaroxaban.
Ishihara H; Torii H; Imoto H; Oka F; Sadahiro H; Suzuki M
J Stroke Cerebrovasc Dis; 2014; 23(10):e457-e459. PubMed ID: 25280819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
